Anglo-French Drugs & Industries Limited has informed the Exchange that a meeting of the Board of Directors of the Company is scheduled to be held on February 06, 2023; inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and financial year ended December 31, 2022.

Anglo French Drugs & Industries Limited has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2022, inter alia to consider the following Businesses.

1. To consider and take on record the Unaudited Financial Results for the second quarter ended September 30, 2022 Report thereon.
2. Any other Business with the permission of the Chair.

Further, the trading window for dealing in securities of the Company for Designated Persons and Immediate Relatives of Designated Persons will be closed with effect from October 01, 2022, till the conclusion of 48 hours after the declaration of Unaudited Financial Results for the second quarter ended September 30, 2022.

Anglo-French Drugs & Industries Limited has informed the Exchange that a meeting of the Board of Directors of the Company is scheduled to be held on August 10, 2022, inter-alia to transact the following business:
1. To consider and approve unaudited Financial Results of the Company for the quarter ended June 30, 2022.
2. Any other matter with the permission of the Chair.

Anglo-French Drugs & Industries Limited has informed the Exchange that a meeting of the Board of Directors of the Company is scheduled to be held on May 12, 2022, inter alia to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2022 and other matters to be considered with permission of the chair.

Further, Trading window for dealing in securities of the Company for directors/officers/designated persons/ specifies persons and their immediate has been closed from April 01, 2022 till the expiry of 48 hours (both days inclusive) after the declaration of the financial results.

Anglo-French Drugs & Industries Limited has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 14, 2022, to consider and take on record the Unaudited Financial Results for the Quarter ended December 31, 2021.
Further, trading window for dealing in securities of the Company for directors/officers/designated employees of the Company shall remain closed from January 01, 2022 till 48 hours after declaration of the Un-audited Financial Results for the Quarter ended December 31, 2021.